W
WLC

Best Longevity Clinics in Japan (2026)

Japan's longevity clinic market sits at the intersection of executive health screening, advanced imaging, regenerative medicine interest, and a national culture associated with long life expectancy. Tokyo is the primary hub, with clinics offering high-end diagnostics, hotel-based screening, nutrition, and selected regenerative or wellness services for domestic and international patients.

2 clinics Editorially reviewed and compared

Regulatory Context

Japanese medical services are overseen by the Ministry of Health, Labour and Welfare (MHLW), while medicines and devices are reviewed through the Pharmaceuticals and Medical Devices Agency (PMDA). Regenerative medicine is governed by specific Japanese safety legislation and committee review pathways. Patients should verify facility notifications, physician credentials, treatment classification, evidence level, and whether a regenerative intervention is approved care, clinical research, or a private wellness-adjacent service.

Compare Japan Clinics Side by Side

Clinic City WLC Score Features Price Range Category
Prevention Clinic Tokyo 76 3/15 JPY 300,000–1,500,000 outpatient
The Hundred Tokyo 69 2/15 JPY 550,000–3,000,000 outpatient

Frequently Asked Questions

Common questions about longevity clinics in Japan.

What are Japan longevity clinics best known for?

Japan is especially strong in executive screening, imaging, endoscopy, biomarker testing, and highly organized service delivery. Some clinics also market NMN, immune, or regenerative services, which require careful review of evidence and regulatory status.

Can international patients use longevity clinics in Tokyo?

Yes, but language support, report translation, scheduling, and follow-up vary by clinic. International patients should confirm English-language medical reports and whether their home physician can receive results for continuity of care.

How should patients evaluate regenerative medicine claims in Japan?

Ask for the treatment category, facility notification or approval pathway, cell source, processing method, expected benefits, known risks, published evidence, and post-treatment monitoring plan. Do not rely on marketing language alone.